Neuroendocrine cancer in lung.
As a result, neuroendocrine cancer in lung medical management has been rigorously quantified in terms of clinical-histological characteristics and the invasive tumour stage, the degree of mediastinal lymph node extension and the presence of distant metastases determined with the TNM staging system that is recognised globally The x-ray examination reveals only pathological mediastinal lymph nodes that cause changes of mediastinal margins and the pleural reflection lines.
The disadvantage of the traditional x-ray examination is the impossibility to identify the lymph nodes situated within the mediastinum.
NOU TRATAMENT PENTRU CANCERUL NEUROENDOCRIN
Also neuroendocrine cancer in lung the lymph nodes are hidden behind other tumour masses existing in the mediastinum, they cannot be discovered at the x-ray examination, which offers little information about the mediastinal structure: vessels, lung, pericardium, pleura, and thoracic wall.
Due to the possibility to reveal all groups of pathological mediastinal lymph nodes, computed neuroendocrine cancer in lung is the first choice examination for the diagnosis of mediastinal adenopathies.
Besides the traditional, cytological and histopathological methods that enable the identification of pulmonary neuroendocrine carcinoma, its malignancy degree and stage, the immunohistochemical methods are very valuable for the assessment of neuroendocrine cancer in lung evolution capacity of neuroendocrine cancer in lung neoplasia. The lung can be subjected to a large variety of complementary investigations.
Keywords: mediastinal lymphadenopathy, broncho-pulmonary neoplasm, pulmonary neuroendocrine tumours, radio-imaging examinations Issue: Volume 67, Number 6.